230 related articles for article (PubMed ID: 21157892)
21. High incidence of TEL/AML1 fusion resulting from a cryptic t(12;21) in childhood B-lineage acute lymphoblastic leukemia in Taiwan.
Liang DC; Chou TB; Chen JS; Shurtleff SA; Rubnitz JE; Downing JR; Pui CH; Shih LY
Leukemia; 1996 Jun; 10(6):991-3. PubMed ID: 8667657
[TBL] [Abstract][Full Text] [Related]
22. TEL deletion analysis supports a novel view of relapse in childhood acute lymphoblastic leukemia.
Zuna J; Ford AM; Peham M; Patel N; Saha V; Eckert C; Köchling J; Panzer-Grümayer R; Trka J; Greaves M
Clin Cancer Res; 2004 Aug; 10(16):5355-60. PubMed ID: 15328172
[TBL] [Abstract][Full Text] [Related]
23. Late ovarian relapse of TEL/AML1 positive ALL confirming that TEL deletion is a secondary event in leukemogenesis.
Ly-Sunnaram B; Henry C; Gandemer V; Mee FL; Burtin F; Blayau M; Cayuela JM; Oster M; Clech P; Rambeau M; Marie C; Pampin C; Edan C; Gall EL; Goasguen JE
Leuk Res; 2005 Sep; 29(9):1089-94. PubMed ID: 16038737
[TBL] [Abstract][Full Text] [Related]
24. TEL-AML1 frequency in multi-ethnic Malaysian pediatric acute lymphoblastic leukemia.
Gill HK; Keoh TS; Dhaliwal JS; Moore S; Kim TS; Hassan R; Karim FA; Zakaria Z; Murad S; Mohamed M; Li Ho CM; Ibrahim H; Rahman EJ
Cancer Genet Cytogenet; 2005 Jan; 156(2):129-33. PubMed ID: 15642392
[TBL] [Abstract][Full Text] [Related]
25. TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K
Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275
[TBL] [Abstract][Full Text] [Related]
26. Role of the TEL-AML1 fusion gene in the molecular pathogenesis of childhood acute lymphoblastic leukaemia.
Zelent A; Greaves M; Enver T
Oncogene; 2004 May; 23(24):4275-83. PubMed ID: 15156184
[TBL] [Abstract][Full Text] [Related]
27. Three distinct domains in TEL-AML1 are required for transcriptional repression of the IL-3 promoter.
Uchida H; Downing JR; Miyazaki Y; Frank R; Zhang J; Nimer SD
Oncogene; 1999 Jan; 18(4):1015-22. PubMed ID: 10023677
[TBL] [Abstract][Full Text] [Related]
28. Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
Mosad E; Hamed HB; Bakry RM; Ezz-Eldin AM; Khalifa NM
J Hematol Oncol; 2008 Oct; 1():17. PubMed ID: 18928518
[TBL] [Abstract][Full Text] [Related]
29. Prenatal origin of TEL-AML1-positive acute lymphoblastic leukemia in children born in California.
McHale CM; Wiemels JL; Zhang L; Ma X; Buffler PA; Guo W; Loh ML; Smith MT
Genes Chromosomes Cancer; 2003 May; 37(1):36-43. PubMed ID: 12661004
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of TEL/AML1 fusion gene in Brazilian pediatric patients with acute lymphoblastic leukemia.
Zen PR; Lima MC; Coser VM; Silla L; Daudt L; Fernandes MS; Neumann J; Mattevi MS; Ortigara R; Paskulin GA
Cancer Genet Cytogenet; 2004 May; 151(1):68-72. PubMed ID: 15120912
[TBL] [Abstract][Full Text] [Related]
31. Co-existence of multiple subclones in TEL-AML1 at diagnosis of acute lymphoblastic leukaemia in association with submicroscopic deletion of AML1.
Rothman R; Trakhtenbrot L; Bielorai B; Izraeli S; Ishoev G; Amariglio N; Rechavi G; Toren A
Br J Haematol; 2005 May; 129(4):491-8. PubMed ID: 15877731
[TBL] [Abstract][Full Text] [Related]
32. [Study of the childhood acute lymphoblastic leukemia with t(12;21)].
Lin D; Liu SH; Zhu XF; Bo LJ; Li CW; Chen YM; Liu XP; Qin S; Dai Y; Wang JX
Zhonghua Xue Ye Xue Za Zhi; 2004 Jan; 25(1):17-21. PubMed ID: 14990071
[TBL] [Abstract][Full Text] [Related]
33. TEL/AML1 overcomes drug resistance through transcriptional repression of multidrug resistance-1 gene expression.
Asakura K; Uchida H; Miyachi H; Kobayashi H; Miyakawa Y; Nimer SD; Takahashi H; Ikeda Y; Kizaki M
Mol Cancer Res; 2004 Jun; 2(6):339-47. PubMed ID: 15235109
[TBL] [Abstract][Full Text] [Related]
34. Structure and possible mechanisms of TEL-AML1 gene fusions in childhood acute lymphoblastic leukemia.
Wiemels JL; Greaves M
Cancer Res; 1999 Aug; 59(16):4075-82. PubMed ID: 10463610
[TBL] [Abstract][Full Text] [Related]
35. TEL/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis.
Shurtleff SA; Buijs A; Behm FG; Rubnitz JE; Raimondi SC; Hancock ML; Chan GC; Pui CH; Grosveld G; Downing JR
Leukemia; 1995 Dec; 9(12):1985-9. PubMed ID: 8609706
[TBL] [Abstract][Full Text] [Related]
36. Equal frequency of TEL/AML1 rearrangements in children with acute lymphoblastic leukemia with and without Down syndrome.
Steiner M; Attarbaschi A; König M; Nebral K; Gadner H; Haas OA; Mann G;
Pediatr Hematol Oncol; 2005; 22(3):229-34. PubMed ID: 16020107
[TBL] [Abstract][Full Text] [Related]
37. TEL/AML1 fusion gene is a rare event in adult acute lymphoblastic leukemia.
Raynaud S; Mauvieux L; Cayuela JM; Bastard C; Bilhou-Nabera C; Debuire B; Bories D; Boucheix C; Charrin C; Fière D; Gabert J
Leukemia; 1996 Sep; 10(9):1529-30. PubMed ID: 8751475
[No Abstract] [Full Text] [Related]
38. CD9 expression can be used to predict childhood TEL/AML1-positive acute lymphoblastic leukemia: proposal for an accelerated diagnostic flowchart.
Gandemer V; Aubry M; Roussel M; Rio AG; de Tayrac M; Vallee A; Mosser J; Ly-Sunnaram B; Galibert MD
Leuk Res; 2010 Apr; 34(4):430-7. PubMed ID: 19896186
[TBL] [Abstract][Full Text] [Related]
39. A t(12;17)(p13;q12) identifies a distinct TEL rearrangement-negative subtype of precursor-B acute lymphoblastic leukemia.
Reid AG; Seppa L; von der Weid N; Niggli FK; Betts DR
Cancer Genet Cytogenet; 2006 Feb; 165(1):64-9. PubMed ID: 16490598
[TBL] [Abstract][Full Text] [Related]
40. Analysis of TEL proteins in human leukemias.
Poirel H; Lacronique V; Mauchauffé M; Le Coniat M; Raffoux E; Daniel MT; Erickson P; Drabkin H; MacLeod RA; Drexler HG; Ghysdael J; Berger R; Bernard OA
Oncogene; 1998 Jun; 16(22):2895-903. PubMed ID: 9671410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
